Joseph W. Ricigliano, Ph.D.

Joe Ricigliano is a Partner in the firm’s Patent practice focusing on intellectual property, patent counseling, portfolio management, and strategy assessment. He has previously examined, prosecuted and counseled clients on a broad variety of technologies including life sciences (biochemical, immunological, pharmaceutical, agricultural, and medical device) applications and chemical/material science related applications. His experience includes prosecution and counseling related to complex immune protein constructs as therapeutics and protein conjugates for drug delivery. He also has substantial experience in high-tech coating technology, combinatorial chemistry (chemical diversity technologies including antibody and phage display), and diverse material science technologies including electroplating and nanomaterials (e.g., nanometals, nanocomposites and surface coating technologies). Joe has prepared and prosecuted both U.S. and foreign patent applications, working with scientists and in-house counsel to identify patentable subject matter and to secure its protection. He has advised pharmaceutical industry and clinical laboratory clients on compliance with the Clinical Laboratory Improvements Acts (CLIA). In addition, he has conducted investigations and advised clients on matters related to CLIA noncompliance issues and events. Joe has numerous years of laboratory experience prior to becoming an attorney. His research interests included viral mechanisms and pathogenesis and the development of steroidal based therapeutics including steroidal immunomodulators and evaluation of their mechanisms of action.

• District of Columbia
• State of Virginia
• Registered to practice before the U.S. Patent and Trademark Office

• American University Washington College of Law, J.D., cum laude, 2005
• Waksman Institute of Microbiology, Postdoctoral Fellow
• The University of Pennsylvania, Ph.D., Dept. of Biochemistry and Biophysics
• Rutgers, The State University of New Jersey, B.A., Biochemistry, with highest distinction

• IPO U.S. Patent Law Committee Section, Current Member
• American Bar Association, Nanotechnology Section, Former Member
• Former Organizer/Coordinator for the American University/Washington College of Law’s International Patent Webinar Series

• Carnegie Institution of Washington et al. v. Pure Grown Diamonds, Inc. et al., 1:20-cv-00189, S.D.N.Y. 2020
• Carnegie Institution of Washington et al v. ALTR, Inc. et al., 1:20-cv-00198
• U.S. Water Services, et al. v. Novozymes A/S, et al.
• Modumetal Inc. v. Integran Technologies Inc.
• Modumetal, Inc. v. Xtalic Corporation
• Eppendorf AG, et al. v. Nanosphere Inc.
• General Electric Company v. Martin R. Prince